Hygiena 2014, 59(1):32-36 | DOI: 10.21101/hygiena.a1193

Circadian Disruptors and Their Importance in Primary Prevention

Drahoslava Hrubá
Masarykova univerzita, Lékařská fakulta, Ústav preventivního lékařství, Brno

All vertebrates, including humans, have a biological circadian clock. Their receptors are located on the retina, and information regarding the alternation of day and night are transferred to a centre in the hypothalamus and from there into the pineal gland which produces melatonin (N-acetyl-5-metoxytryptamin), almost exclusively during the hours of darkness. The hormone is quickly discharged into the bloodstream and cerebrospinal fluid into all cells. Such immediate information about the circadian phase of day/night changes allows to organs and organism to regulate their physiological functions. Current research suggests that melatonin is involved in several important physiological functions: sleep regulation and circadian rhythms, mood, immunity, oncostatic and antioxidant activities. Synthesis of melatonin reduces with age. Artificial light in the evenings and early mornings reduces the dark part of the day and even brief use of artificial light at night reduces the levels of melatonin produced over a 24-hour period. Air transport over a number of time-zones likewise significantly disrupts melatonin production. The health consequences of the disruption of biologcal rhythms include sleep disorders, higher frequency of some types of cancer, obesity, metabolic syndrome, diabetes and aggravation of some neurodegenerative symptoms. In primary prevention it is necessary to limit the duration of night shifts and educate the public on the importance of night sleep.

Keywords: circadian rhythms, endocrine disruptors (ECD), melatonin, disease prevention

Received: October 2012; Accepted: January 21, 2013; Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubá D. Circadian Disruptors and Their Importance in Primary Prevention. Hygiena. 2014;59(1):32-36. doi: 10.21101/hygiena.a1193.
Download citation

References

  1. Reuss S. The clock in the brain: anatomy of the mammalian circadian timing system. In: Peschke E, editor. Endokrinologie. Stuttgart/Leipzich: Verlag der Sächischen Akademie der Wissenschaften zu Leipzich; 2003. p. 9-48. (In German.)
  2. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001 Aug 15;21(16):6405-12. Go to original source... Go to PubMed...
  3. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, Hogenesch JB, et al. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science. 2002 Dec 13;298(5601):2213-6. Go to original source... Go to PubMed...
  4. Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther. 2009 Dec;8(4):303-8. Go to original source... Go to PubMed...
  5. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003 Aug;4(8):649-61. Go to original source... Go to PubMed...
  6. Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol. 1991 Aug;79(1-3):C153-8. Go to original source... Go to PubMed...
  7. Srinivasan V, Cardinali DP, Pandi-Perumal SR, Brown GM. Melatonin agonists for treatment of sleep and depressive disorders. J Exp Integr Med. 2011;1(3):149-58. Go to original source...
  8. Reiter RJ, Gultekin F, Flores LJ, Terron MP, Tan DX. Melatonin: Potential utility for improving public health. TAF Prev Med Bull. 2006;5(2):131-48. Go to original source...
  9. Jasser SA, Blask DE, Brainard GC. Light during darkness and cancer: relationships in circadian photoreception and tumor biology. Cancer Causes Control. 2006 May;17(4):515-23. Go to original source... Go to PubMed...
  10. Lincoln GA, Clarke IJ, Hut RA, Hazlerigg DG. Characterizing a mammalian circannual pacemaker. Science. 2006 Dec 22;314(5807):1941-4. Go to original source... Go to PubMed...
  11. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: nature's most versatile biological signal? FEBS J. 2006 Jul;273(13):2813-38. Go to original source... Go to PubMed...
  12. von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 2002 Jul;309(1):151-62. Go to original source... Go to PubMed...
  13. Czeisler CA, Shanahan TL, Klerman EB, Martens H, Brotman DJ, Emens JS, et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med. 1995 Jan 5;332(1):6-11. Go to original source... Go to PubMed...
  14. Brainard GC, Rollag MD, Hanifin JP. Photic regulation of melatonin in humans: ocular and neural signal transduction. J Biol Rhythms. 1997 Dec;12(6):537-46. Go to original source... Go to PubMed...
  15. Reiter RJ, Tan DX, Sanchez-Barcelo E, Mediavilla MD, Gitto E, Korkmaz A. Circadian mechanisms in the regulation of melatonin synthesis: disruption with light at night and the pathophysiological consequences. J Exp Integr Med. 2011;1(1):13-22. Go to original source...
  16. Poeggeler B. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine. 2005 Jul;27(2):201-12. Go to original source... Go to PubMed...
  17. Pukkala E, Aspholm R, Auvinen A, Eliasch H, Gundestrup M, Haldorsen T, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. 2002 Sep 14;325(7364):567. Go to original source... Go to PubMed...
  18. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev. 1991 May;12(2):151-80. Go to original source... Go to PubMed...
  19. Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP. Melatonin and sleep in aging population. Exp Gerontol. 2005 Dec;40(12):911-25. Go to original source... Go to PubMed...
  20. Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control. 2001 Feb;12(2):95-101. Go to original source... Go to PubMed...
  21. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005 Sep;41(13):2023-32. Go to original source... Go to PubMed...
  22. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006 Jan;17(1):108-11. Go to original source...
  23. Harder B. Bright lights, big cancer. Sci News. 2006;169:8-10. Go to original source...
  24. Erren TC, Reiter RJ. A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol Lett. 2008 Dec;29(6):815-21. Go to PubMed...
  25. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007 Dec;8(12):1065-6. Go to original source... Go to PubMed...
  26. Cos S, Mediavilla D, Martínez-Campa C, González A, AlonsoGonzález C, Sánchez-Barceló EJ. Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats. Cancer Lett. 2006 Apr 28;235(2):266-71. Go to original source... Go to PubMed...
  27. Filipski E, Li XM, Lévi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control. 2006 May;17(4):509-14. Go to original source... Go to PubMed...
  28. Davidson AJ, Sellix MT, Daniel J, Yamazaki S, Menaker M, Block GD. Chronic jet-lag increases mortality in aged mice. Curr Biol. 2006 Nov 7;16(21):R914-6. Go to original source... Go to PubMed...
  29. Korkmaz A, Manchester LC. Reactive nitrogen species; devastating intracellular players and melatonin as a defender. J Exp Integr Med. 2011;1(2):63-65. Go to original source...
  30. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007 Jan;87(1):315-424. Go to original source... Go to PubMed...
  31. Hardeland R. Melatonin and its metabolites as anti-nitrosating and anti-nitrating agents. J Exp Integr Med. 2011;1(2):67-81. Go to original source...
  32. Reiter RJ, Manchester LC, Tan DX. Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition. 2005 Sep;21(9):920-4. Go to original source... Go to PubMed...
  33. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med. 2009 Jan-Feb;15(1-2):43-50. Go to original source... Go to PubMed...
  34. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002 Feb;2(2):113-32. Go to original source...
  35. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci. 2003 Jul;60(7):1407-26. Go to original source... Go to PubMed...
  36. Sánchez-Barceló EJ, Cos S, Mediavilla D, Martínez-Campa C, González A, Alonso-González C. Melatonin-estrogen interactions in breast cancer. J Pineal Res. 2005 May;38(4):217-22. Go to original source... Go to PubMed...
  37. Sainz RM, Mayo JC, Tan DX, Lopez-Burillo S, Natarajan M, Reiter RJ. Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Biophys Res Commun. 2003 Mar 14;302(3):625-34. Go to original source...
  38. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992 May;11(5):1921-9. Go to original source... Go to PubMed...
  39. Boldrini L, Gisfredi S, Ursino S, Faviana P, Lucchi M, Melfi F, et al. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma. Eur J Cancer. 2005 Dec;41(18):2828-35. Go to original source... Go to PubMed...
  40. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005 May 13;308(5724):1043-5. Go to original source... Go to PubMed...
  41. Heldmaier G, Hoffmann K. Melatonin stimulates growth of brown adipose tissue. Nature. 1974 Jan 25;247(438):224-5. Go to original source...
  42. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009 Apr 9;360(15):1518-25. Go to original source... Go to PubMed...
  43. Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens. 2005 Dec;18(12 Pt 1):1614-8. Go to original source... Go to PubMed...
  44. Reiter RJ, Tan DX. Melatonin and cardiac pathophysiology. Heart Metab. 2009;44:31-4.
  45. Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, et al. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. Biochemistry. 2001 Dec 11;40(49):14995-5001. Go to original source...
  46. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res. 2005 Apr;38(3):145-52. Go to original source... Go to PubMed...
  47. Asayama K, Yamadera H, Ito T, Suzuki H, Kudo Y, Endo S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch. 2003 Aug;70(4):334-41. Go to original source... Go to PubMed...
  48. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005 Feb;9(1):41-50. Go to original source... Go to PubMed...
  49. Lam RW. Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S25-9. Go to original source... Go to PubMed...
  50. Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):512-9. Go to original source... Go to PubMed...
  51. Galli-Carminati G, Deriaz N, Bertschy G. Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study. Swiss Med Wkly. 2009 May 16;139(19-20):293-6. Go to original source... Go to PubMed...
  52. Illnerová H, Sumová A. Vnitřní časový systém. Medicína pro praxi. 2011;8(9):374-8.